APA (7th ed.) Citation

PJ, S., L, C., MK, Y., L, T., NE, M., B, J., . . . PM, P. (2020). Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer. Cancer research, 80(17), 3507. https://doi.org/10.1158/0008-5472.CAN-19-3934

Chicago Style (17th ed.) Citation

PJ, Slavish, et al. "Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents Against MYC-Driven Pediatric Cancer." Cancer Research 80, no. 17 (2020): 3507. https://doi.org/10.1158/0008-5472.CAN-19-3934.

MLA (9th ed.) Citation

PJ, Slavish, et al. "Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents Against MYC-Driven Pediatric Cancer." Cancer Research, vol. 80, no. 17, 2020, p. 3507, https://doi.org/10.1158/0008-5472.CAN-19-3934.